PROSTATE
NOMOGRAM
-
Pre-Treatment
Enter your information below and click "Calculate" for results.
Pre-Treatment
Post-Radical Prostatectomy
Hormone Refractory
PSA Doubling Time
Life Expectancy
Volume
Pre-Treatment PSA
Primary Gleason at Biopsy
1
2
3
4
5
Secondary Gleason at Biopsy
1
2
3
4
5
Biopsy Gleason Sum
2
3
4
5
6
7
8
9
10
1992 Clinical Tumor Stage
T1a
T1b
T1c
T2a
T2b
T2c
T3a
T3b
T3c
1997 Clinical Tumor Stage
T1a
T1b
T1c
T2a
T2b
T3a
T3b
Prescribed External Radiation Dose
Current Age
# Positive Cores
# Negative Cores
% Positive Cores
Neo-Adjuvant Hormones
Neo-Adjuvant Radiation
Prostate Volume
# Negative Biopsy Sessions
Cancerous Tissue Length
Non-Cancerous Tissue Length
% Cancer at Base
% Positive Lymph Nodes
1.5
2.0
2.1
3.2
4.6
7.0
Side-Specific Details:
Left
Right
1992 Tumor Stage
T1a
T1b
T1c
T2a
T2b
T2c
T3a
T3b
T3c
T1a
T1b
T1c
T2a
T2b
T2c
T3a
T3b
T3c
% Positive Cores
% Cancer at Base
Primary Gleason
1
2
3
4
5
1
2
3
4
5
Secondary Gleason
1
2
3
4
5
1
2
3
4
5
Indolent Cancer
Organ Confined Disease
Extra Capsular Extension
Seminal Vesicle Invasion
Lymph Node Involvement
Progression Free Probability Radical Prostatectomy
5 Year
10 Year
5 Year Progression Free Probability w/ External Beam Radiation Therapy
5 Year Progression Free Probability w/ Brachytherapy
Mets Probability After Radiation Tx
5 Year
8 Year
Indolent Cancer
N/A
Organ Confined Disease
Extra Capsular Extension
Seminal Vesicle Invasion
Lymph Node Involvement
Progression Free Probability Radical Prostatectomy
5 Year
10 Year
N/A
5 Year Progression Free Probability w/ External Beam Radiation Therapy
5 Year Progression Free Probability w/ Brachytherapy
Mets Probability After Radiation Tx
N/A
ABOUT
|
DISCLAIMER
|
CONTACT US
©2008 Memorial Sloan-Kettering Cancer Center